- Location
1
result for "
Striverdi Respimat
"-
Boehringer Ingelheim Has Obtained Marketing Approval for Striverdi Respimat
Oct 23, 2013Boehringer Ingelheim has obtained marketing approval for Striverdi Respimat (olodaterol), a long-lasting bronchodilator indicated for chronic obstructive pulmonary disease (COPD), in the UK, Denmark and Iceland. This approval is based ...